*Opium Alkaloids DOI: http://dx.doi.org/10.5772/intechopen.91326*

Philadelphia, PA: Lippincott-Raven; 1998. pp. 687-711

[74] Osol A, Hoover JE, et al. Remington's Pharmaceutical Sciences. In: Osol A, Hoover JE, editors. 15th ed. Easton, Pennsylvania: Mack Publishing Co.; 1975. p. 805

[75] Ramanathan VS, Chandra P. Recovery, separation and purification of narcotine and papaverine from Indian opium. Bulletin on Narcotics. 1981;**33**: 55-64

[76] National Cancer İnstitute. Noscapine [Internet]. 2019. Available from: https://ncit.nci.nih.gov/ncitb rowser/ConceptReport.jsp?dictionary= NCI\_Thesaurus&ns=NCI\_Thesaurus&c ode=C80589

[77] Goodman LS, Gilman A. In: Goodman LS, Gilman A, editors. The Pharmacological Basis of Therapeutics. 5th ed. New York: Macmillan Publishing Co., Inc.; 1975. p. 279

[78] Gutstein HB, Akil H. Opioid analgesics. In: Hardman JG, Limbird LE, Gilman AG, McGraw-Hill, editors. The Pharmacological Basis of Therapeutics. 10th ed. New York, NY; 2001. pp. 569-611

[79] Dahlström B, Mellstrand T, Löfdahl CG, Johansson M. Pharmacokinetic properties of noscapine. European Journal of Clinical Pharmacology. 1982;**22**:535-539. DOI: 10.1007/bf00609627

[80] Tsunoda N, Yoshimura H. Metabolic fate of noscapine. II. Isolation and identification of novel metabolites produced by CdC bond cleavage. Xenobiotica. 1979;**9**:181-187. DOI: 10.3109/00498257909038719

[81] American Medical Association, AMA Department of Drugs. AMA Drug Evaluations. 3rd ed. Littleton,

Massachusetts: PSG Publishing Co., Inc.; 1977. p. 667

[82] American Academy of Pediatrics Committee on Drugs. The transfer of drugs and other chemicals into human milk. Pediatrics. 1994;**93**:137-150

[83] Troy DB. In: Troy DB, editor. Remmington: The Science and Practice of Pharmacy. 21st ed. Philadelphia, PA: Lippincott Williams & Williams; 2005. p. 1527

[84] Baselt RC, Cravey RH. Disposition of Toxic Drugs and Chemicals in Man. 4th ed. Foster City, CA, USA: Chemical Toxicology Institute; 1995. pp. 191-194

[85] Dart RC. In: Dart RC, editor. Medical Toxicology. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins.; 2004. p. 761

[86] Gossel TA, Bricker JD. Principles of Clinical Toxicology. 3rd ed. New York, NY: Raven Press, Ltd.; 1994. p. 298

[87] Yazdy MM, Mitchell AA, Tinker SC, Parker SE, Werler MM. Periconceptional use of opioids and the risk of neural tube defects. Obstetrics and Gynecology. 2013;**122**:838-844. DOI: 10.1097/AOG.0b013e3182a6643c

[88] Nair V, Soraisham AS, Akierman A. Neonatal withdrawal syndrome due to maternal codeine use. Paediatrics & Child Health. 2012;**17**:e40-e41. DOI: 10.1093/pch/17.5.e40

[89] Meny RG, Naumburg EG, Alger LS, Brill-Miller JL, Brown S. Codeine and the breastfed neonate. Journal of Human Lactation. 1993;**9**:237-240. DOI: 10.1177/089033449300900423

[90] Lam J, Matlow JN, Ross CJ, Hayden MR, Carleton BC, Madadi P. Postpartum maternal codeine therapy and the risk of adverse neonatal

outcomes: The devil is in the details. Therapeutic Drug Monitoring. 2012;**34**: 378-380. DOI: 10.1097/FTD.0b013e31 825da19f

[91] The Merck Index. 11th ed. Title 21 Part 1308.12. 1985

[92] Kaneda T, Takeuchi Y, Matsui H, Shimizu K, Urakawa N, Nakajyo S. Inhibitory mechanism of papaverine on carbachol-induced contraction in bovine trachea. Journal of Pharmacological Sciences. 2005;**98**:275-282. DOI: 10.1254/jphs.fpj05013x

[93] Stiefel MF, Spiotta AM, Udoetuk JD, Maloney-Wilensky E, Weigele JB, Hurst RW, et al. Intra-arterial papaverine used to treat cerebral vasospasm reduces brain oxygen. Neurocritical Care. 2006;**4**:113-118. DOI: 10.1385/NCC:4:2:113

[94] Pfizer New Zealand Limited. DBL Papaverine hydrochloride injection product data sheet [İnternet]. 2017. Available from: http://www.medsafe. govt.nz/profs/Datasheet/d/dblPapave rineHydrochlorideinj

[95] National Cancer İnstitute. Papaverine [Internet]. 2019. Available from: https://ncit.nci.nih.gov/ncitb rowser/ConceptReport.jsp?dictionary= NCI\_Thesaurus&ns=NCI\_Thesaurus&c ode=C726

[96] Wolf CE, Pierce KL, Goldfine BL, Nanco CR, Poklis JL, Korzun WJ. Using papaverine and its metabolites, 6-desmethyl papaverine and 4',6 didesmethyl papaverine as biomarkers to improve the detection time of heroin use. Journal of Analytical Toxicology. 2019;**43**:600-606. DOI: 10.1093/jat/ bkz069

[97] US Natl Inst Health; DailyMed. Current Medication Information for Papaverine hydrochloride injection, solution, 2012. Available from: http:// dailymed.nlm.nih.gov/dailymed/

lookup.cfm?setid=9e5e2ce4-7a57-4c61-a 826-64c8d11d038e

[98] RxList. Papaverine injection [Internet]. 2019. Available from: https:// www.rxlist.com/papaverine-injectiondrug.htm#overdosage
